Approval · Notice of Compliance 34698 · 2025
MINT-SILDENAFIL: Notice of Compliance 34698
Issued January 16, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34698
- Date
- January 16, 2025
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Reactivation of strength: 25 mg. Update to package labels. New package insert
- Canadian reference product
- VIAGRA (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-SILDENAFIL | Not yet assigned | — |
| MINT-SILDENAFIL | 02393069 | Marketed |
Medicinal ingredients
- SILDENAFIL CITRATE 50 MG per TAB
- SILDENAFIL CITRATE 100 MG per TAB
- SILDENAFIL CITRATE 25 MG per TAB